mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
VU0155056 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.7 |
mRNA |
Imatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
CIL56 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.7 |
mRNA |
BRD-K24690302 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
BRD-K03536150 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.7 |